36
Participants
Start Date
February 29, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Resveratrol
A blend of low dose resveratrol and either leucine or HMB will be useful nutraceutical strategies for the control of elevated blood glucose in non-diabetic individuals with elevated fasting glucose. The proposed project is designed to evaluate this hypothesis by comparing the effects of resveratrol (50 mg)/leucine (1.11 g) administered twice daily (bid).
resveratrol /HMB
resveratrol (50 mg)/HMB (500 mg) twice daily (bid) with placebo on fasting blood glucose, glucose tolerance, insulin, C-peptide, glucagon, fructosamine and F2-isoprostanes in non-diabetic subjects with elevated fasting blood glucose.
Placebo treatment
Placebo - one tablet taken twice a day by mouth
Facility: Vanderbilt University, Nashville
Nutraceutical Discoveries, Inc.
OTHER
Vanderbilt University
OTHER